Publikationen, an denen er mitarbeitet Susana Mellor Pita (13)

2024

  1. Higher mortality risk from gynaecological neoplasms and non-Hodgkin's lymphoma in patients with systemic lupus erythematosus: an observational study from the Spanish National Registry

    Lupus Science and Medicine, Vol. 11, Núm. 1

  2. IgA Anti-β2-Glycoprotein I Antibodies as Markers of Thrombosis and Severity in COVID-19 Patients

    Viruses, Vol. 16, Núm. 7

  3. Rapid response to anifrolumab in refractory cutaneous lupus erythematosus

    Medicina Clinica, Vol. 162, Núm. 11, pp. 555-556

  4. Sarcoidosis and lymphoma mortality risk: An observational study from the Spanish National Registry

    Journal of Translational Autoimmunity, Vol. 8

2022

  1. Bacterial infections in patients hospitalized with COVID-19

    Internal and Emergency Medicine, Vol. 17, Núm. 2, pp. 431-438

  2. Impact of cardiovascular risk factors in antiphospholipid syndrome: an observational study from the Spanish national registry

    Clinical and experimental rheumatology, Vol. 40, Núm. 11, pp. 2161-2166

  3. Impact of severe infections in SLE: An observational study from the Spanish national registry

    Lupus Science and Medicine, Vol. 9, Núm. 1

  4. Serum cytokines to predict systemic lupus erythematosus clinical and serological activity

    Clinical and Translational Science, Vol. 15, Núm. 7, pp. 1676-1686

  5. Systemic Autoimmune Diseases in Patients Hospitalized with COVID-19 in Spain: A Nation-Wide Registry Study

    Viruses, Vol. 14, Núm. 8

  6. Usefulness of the hemogram as a measure of clinical and serological activity in systemic lupus erythematosus

    Journal of Translational Autoimmunity, Vol. 5

2021

  1. Atrophic violaceus pretibial plaques: when the clue is the oral mucosa

    Clinical and Experimental Dermatology

  2. Trends in hospital admissions and death causes in patients with systemic lupus erythematosus: Spanish national registry

    Journal of Clinical Medicine, Vol. 10, Núm. 24

2020

  1. A retrospective controlled cohort study of the impact of glucocorticoid treatment in SARS-CoV-2 infection mortality

    Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 9